March 19 (Reuters) - CSL Ltd (CSL) :
- FERINJECT® APPROVED BY HEALTH CANADA FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN ADULT AND PEDIATRIC PATIENTS AND IRON DEFICIENCY IN ADULT PATIENTS WITH HEART FAILURE
- CSL LTD: IN CANADA, FERINJECT IS COMMERCIALIZED THROUGH CSL BEHRING CANADA, INC., WITH AVAILABILITY EXPECTED IN SECOND HALF OF 2024
News: CSL Ferinject Approved By Health Canada For The Treatment Of Iron Deficiency Anemia In Adult...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$275.82 |
Change
1.330(0.48%) |
Mkt cap ! $132.5B | |||
| Open | High | Low | Value | Volume |
| $274.68 | $276.45 | $273.87 | $29.00M | 105.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 38 | $275.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $275.83 | 80 | 7 |
View Market Depth
| Last trade - 12.54pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$275.76 |
Change
1.330 ( 0.47 %) |
||||
| Open | High | Low | Volume | ||
| $275.75 | $276.43 | $273.91 | 86749 | ||
| Last updated 13.13pm 02/05/2024 ? | |||||
| CSL (ASX) Chart |